The cost of multiple myeloma treatment in India typically ranges from $4,500 to $18,000, offering patients access to advanced cancer care at a fraction of the cost seen in many Western countries. Multiple myeloma is a complex blood cancer that affects plasma cells in the bone marrow and can lead to complications such as bone damage, anemia, kidney dysfunction, and reduced immunity.
Treatment is tailored to each patient and focuses on controlling disease progression, managing symptoms, and improving long-term survival. Therapeutic options may include targeted therapies, immunotherapy, chemotherapy, and stem cell transplantation, depending on disease stage and patient health.
India has become a leading destination for multiple myeloma medical tourism due to its experienced hematologists, advanced oncology centers, and access to the latest anti-myeloma drugs and transplant facilities. Patients receive evidence-based care aligned with international treatment protocols at globally accredited hospitals. With high-quality treatment and affordable costs, India remains a trusted choice for multiple myeloma care abroad.









